Laurence Debroux

  • Member of the board of Exor N.V. and of HEC Paris Business School.

  • Group chief financial officer, executive board member, of Heineken N.V, 2015-2021.
  • Group chief financial officer, executive board member, at JCDecaux SA, 2010-2015.
  • Chief strategic officer, chief financial officer and deputy chief financial officer at Sanofi Aventis SA, 1996-2010.

  • Considered independent under the Danish Recommendations on Corporate Governance.
  • Member of the Board of Directors since March 2019. Most recently elected in 2021 for a term of one year.
  • Member of the Audit Committee since March 2019 and Chair of the Committee since March 2021. The Board has designated Ms Debroux as financial expert as defined by the US Securities and Exchange Commission (SEC) and assessed that Ms Debroux qualifies as independent pursuant to the US Securities Exchange Act. The Board assessed that Ms Debroux has competences in accounting and auditing as required by the Danish Act on Approved Auditors and Audit Firms.
  • Member of the Remuneration Committee since March 2021.

  • Global corporate leadership
  • Healthcare and pharma industry
  • Finance & accounting
  • Business development, M&A and external innovation sourcing
  • Human capital management
  • Environmental, social and governance (ESG)

  • 1992: Master Degree, HEC Paris, Ecoles des Hautes Etudes Commerciales, France.

French, born 1969. Female.